The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting
Herpes Zoster
About this trial
This is an interventional prevention trial for Herpes Zoster focused on measuring Herpes Zoster, Prevention & control, Pharmacists, Pharmacy, Pharmacies, Aged, Immunization, Vaccination
Eligibility Criteria
Inclusion Criteria:
- men and women aged 60 or older without contraindications for the herpes zoster vaccination
- patients who have already experienced one or more episodes of herpes zoster infection were considered for vaccine receipt and study inclusion secondary to CDC ACIP recommendations
Exclusion Criteria:
- Patients aged < 60 years
- Anyone who has previously received the herpes zoster vaccine
- Anyone with an allergy to neomycin, gelatin or any other component of the vaccine
- Anyone receiving a live vaccine within 4 weeks
- Anyone with a compromised or weakened immune systems such as those receiving radiation, corticosteroids, or those with HIV/AIDS, cancer in the lymph, bone or blood systems
- Pregnant women or those in close contact with a pregnant woman
Sites / Locations
- Wilson Pharmacy
- Marcrom's Pharmacy
- Reeves-Sain Drug Store
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
1
2
Patients voluntarily presenting to community pharmacies who request receipt of the herpes zoster vaccine during the first month of observation. These patients have not been exposed to pharmacist-driven interventions utilized in this study. This group serves as the control group.
Patients voluntarily presenting to community pharmacies who request receipt of the herpes zoster vaccine during the second month of observation. These patients may or may not have been exposed to pharmacist-driven interventions utilized in this study. This group serves as the study/intervention group.